Product Name | MF | CAS | Details |
---|
4-[4-(Dimethylamino)-1-(4-fluorophenyl)-1-hydroxybutyl]-3-(hydroxymethyl)benzonitrile | C20H23FN2O2 | 103146-25-4 | Details |
tert-butyl (1R,2S,5S)-5-(dimethylcarbamoyl)-2-aminocyclohexylcarbamate | C14H27N3O3 | 365998-36-3 | Details |
Ethyl (5-chloropyridin-2-ylcarbamoyl) formate Hydrochloride 99% | C9H10Cl2N2O3 | 1243308-37-3 | Details |
tert-butyl (1R,2S,5S)-5-(dimethylcarbamoyl)-2-aminocyclohexylcarbamate oxalate | C16H29N3O7 | 1210348-34-7 | Details |
Ethyl (5-chloropyridin-2-ylcarbamoyl) formate | C9H9ClN2O3 | 349125-08-2 | Details |
Mica Ester | C15H12N4O4S3 | 246035-38-1 | Details |
Citalorpam hydrobromide API | C20H22BrFN2O | 59729-32-7 | Details |
3-(Trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a] pyrazine Hydrochloride | C6H7F3N4.ClH | 762240-92-6 | Details |
Ethyl 5-(2-hydroxypropan-2-yl)-2-propyl-1H-imidazole-4-carboxylate | C12H20N2O3 | 144689-93-0 | Details |
4-Chloromethyl-5-methyl-1,3-dioxol-2-one | C5H5ClO3 | 80841-78-7 | Details |
Apixaban API | C25H25N5O4 | 503612-47-3 | Details |
(1-(4-Aminophenyl)-5,6-dihydro-3-(4-morpholinyl)-2(1h)-pyridinone) | C15H19N3O2 | 1267610-26-3 | Details |
Tafamidis-meglumine API | C21H24Cl2N2O8 | 951395-08-7 | Details |
Escitalopram oxalate API | C22H23FN2O5 | 219861-08-2 | Details |
3-Morpholino-1-(4-nitrophenyl)-5,6-dihydropyridin-2(1H)-one | C15H17N3O4 | 503615-03-0 | Details |
5,6-Dihydro-3-(4-morpholinyl)-1-[4-(2-oxo-1-piperidinyl)phenyl]-2(1H)-pyridinone | C20H25N3O3 | 545445-44-1 | Details |
6,6-Dimethyl-3-azabicyclo [3.1.0]hexane hydrochloride HCl | C7H14ClN | 943516-55-0 | Details |
Olmesartan medoxomil API | C29H30N6O6 | 144689-63-4 | Details |
Edoxaban tosylate monohydrate | C31H38ClN7O7S2 | 1229194-11-9 | Details |
(5-methyl-4,5,6,7-tetrahydro 1.3thiazolo.5,4-cpyridine-2-carboxylic acid hydrochloride | C8H11ClN2O2S | 720720-96-7 | Details |
Rivaroxaban API | C19H18ClN3O5S | 366789-02-8 | Details |
Ethyl chloro[(4-methoxyphenyl)hydrazono]acetate | C11H13ClN2O3 | 27143-07-3 | Details |
Product Total: Product Page: | ||||
1 |